General Information of the Compound
Compound ID
CP0219563
Compound Name
2-[6-(4-cyclopropylphenyl)thieno[3,2-d]pyrimidin-4-yl]sulfanylacetic acid
    Show/Hide
Structure
Formula
C17H14N2O2S2
Molecular Weight
342.445
Canonical SMILES
OC(=O)CSc1ncnc2cc(sc12)-c1ccc(cc1)C1CC1
    Show/Hide
InChI
InChI=1S/C17H14N2O2S2/c20-15(21)8-22-17-16-13(18-9-19-17)7-14(23-16)12-5-3-11(4-6-12)10-1-2-10/h3-7,9-10H,1-2,8H2,(H,20,21)
    Show/Hide
InChIKey
RUYKWEJPYZQKSG-UHFFFAOYSA-N
Physicochemical Property
logP
4.4124
Rotatable Bonds
5
Heavy Atom Count
23
Polar Areas
63.08
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 146680878
ChEMBL ID
CHEMBL4739879
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02503, Serine/threonine-protein kinase 17B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 530 nM
   TI
   LI
   LO
   TS